Condom use: still a sexual health stapleRichard A. Crosby A B D , Willard Cates Jr C
A College of Public Health at the University of Kentucky, 121 Washington Ave., Lexington, KY 40506, USA.
B The Kinsey Institute for Research on Sex, Gender and Reproduction, 1165 East Third Street #313, Bloomington, IN 47405-3700, USA.
C FHI 360.
D Corresponding author. Email: email@example.com
Sexual Health 9(1) 1-3 https://doi.org/10.1071/SH11111
Submitted: 8 August 2011 Accepted: 1 September 2011 Published: 17 February 2012
This article introduces and summarizes the contents of this special edition. Given the exceptional potential of condoms to avert epidemics of sexually transmitted infections and teen or unintended pregnancy – even in low-resource environments – this in-depth examination of current knowledge, practice, and issues with condoms and their use is an important asset for educators and practitioners worldwide.
Additional keywords: HIV, prevention, safer sex, STI.
The global pandemics of HIV, sexually transmitted infections (STIs) and unintentional pregnancy clearly necessitate innovative prevention strategies.1,2 Although recent biomedical approaches such as antiretroviral (ARV) treatment for persons living with HIV,3 ARV pre-exposure prophylaxis (PrEP) for HIV-negative people at risk of acquisition4–6 and adult male circumcision7,8 programs are valuable assets against the spread of HIV, these biomedical strategies are not a panacea. Moreover, their associated costs are sizeable.9
Condoms are the oldest and most affordable method of HIV prevention. Recent advances in knowledge about the nuances of this method have been spawned by the AIDS pandemic.10 These condom innovations are not always product-oriented; indeed, most involve harnessing the behavioural and social sciences to promote improved frequency and quality of condom use, especially among those at greatest risk.
This special issue of Sexual Health provides state-of-the-art reviews of recent research on both male and female condoms. More importantly, it builds upon the foundation of ‘what we know’ to offer concrete future directions for optimal public health impact. Even today, condom use remains a fundamental prevention practice for both the HIV and STI pandemics, as well as the ongoing global problem of unintentional pregnancy.
The issue opens with Warner and colleagues11 making an eloquent case that condom use is a complex behaviour, embedded in the fabric of gender inequalities. They highlight the need for creative programs to rectify issues that users experience with condoms. They offer a scenario – however utopian – where condom use could be perceived as pleasurable. Indeed, a population-level, sex-positive approach to promoting condom use is an aspirational aspect of this opening commentary. It also touches upon the empirical question of condom effectiveness, an issue dealt with at length in the subsequent article.12
Rather than being an exhaustive review of the extant literature, the condom effectiveness review12 captures the immensely complicated challenges inherent in studies of human sexual behaviour. Prospective observational studies offer a relatively strong body of evidence supporting condom effectiveness even in the presence of the multiple forms of bias towards the null. This suggests that our current condom effectiveness estimates are usually understated. The review concludes that consistent and correct use of condoms is highly effective in protecting against STIs, HIV and unintended pregnancy.
Next, Gallo and colleagues13 describe our current thinking about the female condom. Although the recent technical innovations of new female condoms are exciting, widespread adoption of this prevention strategy remains a challenge. Studies of female condom effectiveness contain similar methodological difficulties to those facing studies of male condoms. Nonetheless, initial evidence suggests female condoms have an STI-protective effect equivalent to the male condom and similar rates of protection against pregnancy. Because the female condom covers more of the female genitalia than the male condom, it could provide an additional level of protection against genital herpes, syphilis and human papillomavirus. They offer the female condom as a viable alternative to the male condom, and outline the future research needed to help solidify its public health niche.
Subsequent reviews cover China, central and eastern Europe, and Sub-Saharan Africa.14–16 Several themes emerge across these three articles, with the need for intensified national education programs being predominant. This, in turn, depends on the different political contexts for condom promotion efforts in the various nations. China exemplifies a nation highly dependent on government initiatives to promote condom use; their current paradigm is largely focussed on the contraceptive role of condoms rather than disease prevention.
Another theme is the low uptake of condom use across diverse high-risk populations. Fortunately, emerging evidence presented by Chapman and colleagues16 suggests that rates of condom use can be substantially increased through innovative social marketing programs such as the one described for Kenya. A central challenge in the coming decades will be to construct programs similar to the Kenyan model while allowing for cultural adaptations and the harsh realities of poverty and gender inequality.
Next, Beksinska and colleagues review progress in and challenges to male and female condom use in South Africa.17 They document steady improvements in knowledge and use of condoms in this high HIV prevalence nation. In addition to creative social marketing programs, South Africa has promoted national policies to facilitate increased condom use. For example, all children aged 12 years and older have access to condoms. The uptake of female condoms is relatively high in South Africa compared with other African nations, although male condom use remains the most cost-effective barrier method. The authors describe multiple behavioural issues regarding male condoms, including intravaginal practices that may interfere with correct use. They also discuss condom use among men who have sex with men.
Also focussing on South Africa, Maticka-Tyndale18 provides a synthesis of cognitive factors affecting the use of male condoms. These include some culturally sensitive perceptions such as the depositing of semen being a display of manliness and the reception of semen being a way to enhance feminine beauty. This article also examines how condom use is influenced by complex social and interpersonal interactions occurring within societal structures and cultures. The article describes the role of parents, peers and sex partners in shaping condom use behaviours. Many of the cognitive and behavioural concepts described (including widespread misconceptions about preventing HIV transmission) may be highly applicable in other African nations.
Turning to pregnancy prevention, Higgins and Cooper19 focus on the simultaneous use of condoms and other forms of contraception. This review of dual-method use in the United States provides insight into the demographic and social correlates of those reporting using two methods. The findings reinforce the importance of expanding peer education, developing programs that reach parents of adolescents, and conducting research with men and couples.
Subsequently, Sanders and colleagues20 provide a review of condom use problems commonly experienced by people in 14 countries. This review illustrates that condom promotion programs are unlikely to be optimally successful without teaching people to navigate the often complicated aspects of correct use. A particularly challenging issue is the all-too-common practice of putting condoms on after penetrative sex begins and removing them before penetrative sex ends. Their article reminds us of the ongoing need to create new educational approaches that will equip people with the skills needed to protect themselves better. They close by suggesting a model that can become an important tool for researchers. The model posits that condom problems may stem from contextual factors and may, in turn, influence consistency of condom use.
Turning attention to the interactive effects of biomedical innovations, Crosby and colleagues21 summarise issues relevant to the concept of risk compensation (also known as disinhibition or condom migration). Risk compensation occurs when the use of one prevention method (e.g. vaginal microbicides) leads people to abandon another method (e.g. condoms). This phenomenon has the potential to minimise the value of prevention strategies such as male circumcision, oral and topical pre-exposure prophylaxis, and vaccines against HIV and other STIs. Biomedical innovations must be developed in parallel with behavioural innovations to optimise prevention-oriented behaviours.
Finally, Graham22 provides a compelling argument for a better integration between the fields of public health and sex research. She reviews studies to suggest that a broader conceptualisation of ‘sexual pleasure’ could greatly add to public efforts aimed at promoting consistent and correct condom use. She introduces the dual-control model as a means of enriching condom use research and she argues for more attention to couple-level designs in condom use research. This article provides a compelling case that concepts such as sexual desire, sexual arousal and pleasure should be focal points in research devoted to improved understandings of condom use behaviours.
In conclusion, male and female condoms are vital in our sexual health toolkit. Used consistently and correctly, they provide dual protection against both STIs (including HIV) and unintended pregnancy. In addition, condoms remain an essential part of the global HIV prevention agenda. We need the full alphabet (A, B, C ... Z), including condoms, of targeted combination prevention to optimise our public health impact and ultimately reverse the pandemic.23 As this special issue shows, our knowledge about how to improve condom adherence at the individual or couple level and condom access at the population level has increased over the past decade. We will continue to apply and evaluate these lessons as we adapt the role of condom use into the always evolving sexual health landscape.
Conflicts of Interest
References UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2010.
 Centers for Disease Control (CDC). Unintended pregnancy prevention. Atlanta: CDC; 2011. Available online at: http://www.cdc.gov/reproductive health/Unintended Pregnancy/index.htm [verified July 2011].
 Cohen MS, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al Prevention of HIV-1 infection with early antiretroviral therapy. New Engl J Med 2011; 365 493–505.
| Prevention of HIV-1 infection with early antiretroviral therapy.CrossRef | 1:CAS:528:DC%2BC3MXhtVars7jF&md5=f138a6629290cce666111ad76b5f97b2CAS |
 Abdool Karim Q, Abdool-Karim S, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329 1168–74.
| Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.CrossRef | 1:CAS:528:DC%2BC3cXhtV2hsr%2FI&md5=8285ce242cb3cffcd596b459dfca99e7CAS |
 Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363 2587–99.
| Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.CrossRef | 1:CAS:528:DC%2BC3MXit1ansg%3D%3D&md5=3fd14e54fb119385722fc2701b34ec8bCAS |
 Baeten J, Donnell D, Celum C. Pre-exposure prophylaxis with antiretroviral drugs in men and women in Africa. 6th IAS Pathogenesis Meeting; July 18, 2011; Rome, Italy.
 Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger I, et al Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369 643–56.
| Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.CrossRef |
 Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial. Lancet 2007; 369 657–66.
| Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial.CrossRef |
 Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, et al Critical choices in financing the response to the global HIV/AIDS pandemic. Health Aff 2009; 28 1591–605.
| Critical choices in financing the response to the global HIV/AIDS pandemic.CrossRef |
 Crosby R, Warner L. Pending issues in male condom use promotion. Sex Health 2008; 5 317–9.
| Pending issues in male condom use promotion.CrossRef |
 Warner L, Gallo M, Macaluso M. Condom use around the globe: how can we fulfill the prevention potential of male condoms? Sex Health 2012; 9 4–9.
| Condom use around the globe: how can we fulfill the prevention potential of male condoms?CrossRef |
 Crosby RA, Bounce S. Condom effectiveness: where are we now? Sex Health 2012; 9 10–17.
| Condom effectiveness: where are we now?CrossRef |
 Gallo M, Kilbourne-Brook M, Coffey PS. A review of the effectiveness and acceptability of the female condom for dual protection. Sex Health 2012; 9 18–26.
| A review of the effectiveness and acceptability of the female condom for dual protection.CrossRef |
 Zou H, Xue H, Wang X, Lu D. Condom use in China: prevalence, policies, issues and barriers. Sex Health 2012; 9 27–33.
| Condom use in China: prevalence, policies, issues and barriers.CrossRef |
 Amirkhanian YA. Review of HIV vulnerability and condom use in central and eastern Europe. Sex Health 2012; 9 34–43.
| Review of HIV vulnerability and condom use in central and eastern Europe.CrossRef |
 Chapman S, Jafa K, Longfield K, Vielot N, Buszin J, Ngamkitpaiboon C, Kays M. Condom social marketing in sub-Saharan Africa and the Total Market Approach. Sex Health 2012; 9 44–50.
| Condom social marketing in sub-Saharan Africa and the Total Market Approach.CrossRef |
 Beksinska M, Smit JA, Mantell JE. Progress and challenges to male and female condom use in South Africa. Sex Health 2012; 9 51–58.
| Progress and challenges to male and female condom use in South Africa.CrossRef |
 Maticka-Tyndale E. Condoms in sub-Saharan Africa. Sex Health 2012; 9 59–72.
| Condoms in sub-Saharan Africa.CrossRef |
 Higgins J, Cooper AD. Dual use of condoms and contraceptives in the USA. Sex Health 2012; 9 73–80.
| Dual use of condoms and contraceptives in the USA.CrossRef |
 Sanders SA, Yarber WL, Kaufman EL, Crosby RA, Graham CA, Milhausen RR. Condom use errors and problems: a global view. Sex Health 2012; 9 81–95.
| Condom use errors and problems: a global view.CrossRef |
 Crosby RA, Ricks J, Young A. Condom migration resulting from circumcision, microbicides, and vaccines: brief review and methodological considerations. Sex Health 2012; 9 96–102.
| Condom migration resulting from circumcision, microbicides, and vaccines: brief review and methodological considerations.CrossRef |
 Graham CA. Condom use in the context of sex research. Sex Health 2012; 9 103–108.
| Condom use in the context of sex research.CrossRef |
 Cates W, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach? Sex Transm Dis 2002; 29 168–74.
| Dual protection against unintended pregnancy and sexually transmitted infections: what is the best contraceptive approach?CrossRef |